An Association between Idiopathic Parkinson's Disease and Polymorphisms of Phase II Detoxification Enzymes: Glutathione S-Transferase M1 and Quinone Oxidoreductase 1 and 2
- 9 November 2001
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 288 (4), 887-892
- https://doi.org/10.1006/bbrc.2001.5868
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Genetics of Parkinsonism: a reviewAnnals of Human Genetics, 2001
- Oxidative Stress and Genetics in the Pathogenesis of Parkinson's DiseaseNeurobiology of Disease, 2000
- Glutathione Transferase M2-2 Catalyzes Conjugation of Dopamine and Dopa o-QuinonesBiochemical and Biophysical Research Communications, 2000
- Drug treatment of Parkinson’s disease: Time for phase IIBiochemical Pharmacology, 2000
- Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effectsBiochimica et Biophysica Acta (BBA) - General Subjects, 1998
- The oxidative metabolism of catecholamines in the brain: a reviewBiochimica et Biophysica Acta (BBA) - General Subjects, 1998
- Human Class Mu Glutathione Transferases, in Particular Isoenzyme M2-2, Catalyze Detoxication of the Dopamine Metabolite AminochromePublished by Elsevier BV ,1997
- Oxidative stress and antioxidant therapy in Parkinson's diseaseProgress in Neurobiology, 1996
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983